Recently, Incor Biotech was once again awarded the "High-tech Enterprise" certificate jointly issued by the Shenzhen Science and Technology Innovation Commission, the Shenzhen Municipal Finance Bureau, and the Shenzhen Taxation Bureau of the State Administration of Taxation.
This recognition is the re-identification of the original high-tech enterprise certificate after the expiration of the three-year validity period, and it is also the third time that the company has passed the "National High-tech Enterprise" assessment.
High-tech enterprises refer to enterprises that continue to carry out research and development and transformation of technological achievements in the "high-tech fields supported by the state", form the core independent intellectual property rights of the enterprise, and carry out business activities on this basis.
In recent years, Incrown Biotech attaches great importance to scientific and technological innovation, continuously optimizes the intellectual property protection system, and promotes the transformation of scientific and technological achievements. Up to now, Incrown Biotech has obtained nearly 30 patents, 1 famous high-tech product, 5 high-tech products, more than 30 scientific and technological research achievements, and 7 Shenzhen enterprise innovation records.
It has been recognized as a national high-tech enterprise for 9 consecutive years, which is a high recognition of the company's technology research and development innovation, achievement transformation and application, enterprise growth, etc., and is also an important embodiment of technical personnel based on their posts and continuous progress. We will take this opportunity and motivation to continue to uphold the corporate values of "innovation, rigor, health and growth", forge ahead on the road of scientific research and technology, and strive to develop more first-class biomedical products for the benefit of human health.